Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Anas Elbashir
17  Ergebnisse:
Personensuche X
?
1

Socioeconomic impacts of elimination of onchocerciasis in A..:

Ahmed, Ayman ; Elbashir, Anas ; Mohamed, Asgad A....
BMC Research Notes.  13 (2020)  1 - p. , 2020
Link: https://doi.org/10.1186/..
 
?
2

Socioeconomic impacts of elimination of onchocerciasis in A..:

Ayman Ahmed ; Anas Elbashir ; Asgad A. Mohamed...
http://link.springer.com/article/10.1186/s13104-020-05101-6.  , 2020
Link: https://doi.org/10.1186/..
 
?
3

Safety and efficacy of paromomycin/miltefosine/liposomal am..:

Younis, Brima Musa ; Mudawi Musa, Ahmed ; Monnerat, Séverine...
PLOS Neglected Tropical Diseases.  17 (2023)  11 - p. e0011780 , 2023
Link: https://doi.org/10.1371/..
 
?
4

Safety and efficacy of paromomycin/miltefosine/liposomal am..:

Brima Musa Younis ; Ahmed Mudawi Musa ; Séverine Monnerat...
https://journals.plos.org/plosntds/article/file?id=10.1371/journal.pntd.0011780&type=printable.  , 2023
Link: https://doi.org/10.1371/..
 
?
5

PKDL lesion distribution grade over time by treatment arm–m..:

Brima Musa Younis ; Ahmed Mudawi Musa ; Séverine Monnerat...
doi:10.1371/journal.pntd.0011780.g003.  , 2023
Link: https://doi.org/10.1371/..
 
?
6

Supplementary material:

Brima Musa Younis ; Ahmed Mudawi Musa ; Séverine Monnerat...
doi:10.1371/journal.pntd.0011780.s001.  , 2023
Link: https://doi.org/10.1371/..
 
?
7

Baseline characteristics by treatment arm and overall–ITT s..:

Brima Musa Younis ; Ahmed Mudawi Musa ; Séverine Monnerat...
doi:10.1371/journal.pntd.0011780.t001.  , 2023
Link: https://doi.org/10.1371/..
 
?
8

Kaplan-Meier curve of time to complete cure by treatment ar..:

Brima Musa Younis ; Ahmed Mudawi Musa ; Séverine Monnerat...
doi:10.1371/journal.pntd.0011780.g002.  , 2023
Link: https://doi.org/10.1371/..
 
?
9

CONSORT 2010 checklist of information to include when repor..:

Brima Musa Younis ; Ahmed Mudawi Musa ; Séverine Monnerat...
doi:10.1371/journal.pntd.0011780.s003.  , 2023
Link: https://doi.org/10.1371/..
 
?
10

Summary of treatment emergent adverse events–mITT set:

Brima Musa Younis ; Ahmed Mudawi Musa ; Séverine Monnerat...
doi:10.1371/journal.pntd.0011780.t003.  , 2023
Link: https://doi.org/10.1371/..
 
?
11

PKDL Sudan Study Synopsis:

Brima Musa Younis ; Ahmed Mudawi Musa ; Séverine Monnerat...
doi:10.1371/journal.pntd.0011780.s002.  , 2023
Link: https://doi.org/10.1371/..
 
?
12

Primary efficacy outcome of definitive cure at 12 months by..:

Brima Musa Younis ; Ahmed Mudawi Musa ; Séverine Monnerat...
doi:10.1371/journal.pntd.0011780.t002.  , 2023
Link: https://doi.org/10.1371/..
 
?
13

Median plasma and skin concentrations of miltefosine on day..:

Brima Musa Younis ; Ahmed Mudawi Musa ; Séverine Monnerat...
doi:10.1371/journal.pntd.0011780.g004.  , 2023
Link: https://doi.org/10.1371/..
 
?
14

Fig 1 -:

Brima Musa Younis ; Ahmed Mudawi Musa ; Séverine Monnerat...
doi:10.1371/journal.pntd.0011780.g001.  , 2023
Link: https://doi.org/10.1371/..
 
?
15

Treatment-emergent ADRs by SOC and PT by treatment arm and ..:

Brima Musa Younis ; Ahmed Mudawi Musa ; Séverine Monnerat...
doi:10.1371/journal.pntd.0011780.t004.  , 2023
Link: https://doi.org/10.1371/..
 
1-15